Direct stimulation of angiotensin II type 2 receptor reduces nitric oxide production in lipopolysaccharide treated mouse macrophages.
Animals
Drug Discovery
Ligands
Lipopolysaccharides
/ immunology
Macrophages
/ drug effects
Mice
Nitric Oxide
/ analysis
Nitric Oxide Synthase Type II
/ metabolism
RAW 264.7 Cells
Receptor, Angiotensin, Type 2
/ agonists
Renin-Angiotensin System
/ drug effects
Sulfonamides
/ pharmacology
Thiophenes
/ pharmacology
Agonist
Antagonist
Bioassay
Functional activity
Inducible nitric oxide synthase
Renin-angiotensin-aldosterone system
Journal
European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354
Informations de publication
Date de publication:
05 Feb 2020
05 Feb 2020
Historique:
received:
11
10
2019
revised:
04
12
2019
accepted:
09
12
2019
pubmed:
15
12
2019
medline:
21
10
2020
entrez:
15
12
2019
Statut:
ppublish
Résumé
The angiotensin II type 2 receptor (AT
Identifiants
pubmed: 31837306
pii: S0014-2999(19)30807-6
doi: 10.1016/j.ejphar.2019.172855
pii:
doi:
Substances chimiques
Ligands
0
Lipopolysaccharides
0
N-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-isobutylthiophene-2-sulfonamide
0
Receptor, Angiotensin, Type 2
0
Sulfonamides
0
Thiophenes
0
Nitric Oxide
31C4KY9ESH
Nitric Oxide Synthase Type II
EC 1.14.13.39
Nos2 protein, mouse
EC 1.14.13.39
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
172855Informations de copyright
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.